(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...
European and US real estate asset manager and investor, Global Mutual, is delighted to announce that phase 1 of the retrofit ...
Hundreds of millions of dollars of life-saving medical supplies are stranded in warehouses and on ships around the world due ...
1don MSNOpinion
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Ben & Jerry's maker Unilever said on Thursday it would spin out its ice cream business and picked Amsterdam for its primary ...
Ben & Jerry's maker Unilever has chosen Amsterdam over London and New York as the primary listing for its ice cream business, ...
Drug developer GSK is vacating its 635,000-square-foot life sciences lab in Rockville, Maryland, where it was the sole tenant ...
The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...
The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...
GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...
Barclays raises British American Tobacco price target to 3,550 (3,250) pence - 'overweight' Bank of America cuts Rolls-Royce price target to 830 (850) pence - 'buy' Barclays cuts Hiscox price target ...
Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback